Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hellmann

Showing results (51-60 of 235) with videos related to

Pageof 24
Sort By:
The Journal of Pediatrics|October 1, 1983
Chronic active Epstein-Barr virus infections in two immunodeficient patientsD Hellmann, M J Cowan, A J Ammann, et al.
Pediatrics|March 1, 1984
Maternal transmission of acquired immune deficiency syndromeM J Cowan, D Hellmann, D Chudwin, et al.
Journal of Oral Rehabilitation|April 10, 2014
Localised task-dependent motor-unit recruitment in the masseterH J Schindler, D Hellmann, N N Giannakopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testingH A Yu, M E Arcila, M D Hellmann, et al.
JTO Clinical and Research Reports|September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLCNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
JAMA Dermatology|December 13, 2018
Clinical Characterization of Immunotherapy-Related Pruritus Among Patients Seen in 2 Oncodermatology ClinicsGregory S Phillips, Azael Freites-Martinez, Jennifer Wu, et al.
Clinical Lung Cancer|May 25, 2015
Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung CancersMatthew D Hellmann, Isrid Sturm, Zuzana Jirakova Trnkova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinibMatthew D Hellmann, Boris Reva, Helena Yu, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1991
Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cellsM Schmitt, N Chucholowski, E Busch, et al.
IEEE Transactions on Medical Imaging|July 25, 2018
Multiple Resolution Residually Connected Feature Streams for Automatic Lung Tumor Segmentation From CT ImagesJue Jiang, Yu-Chi Hu, Chia-Ju Liu, et al.
Pageof 24

Showing results (51-60 of 235) with videos related to

Sort By:
Pageof 24
The Journal of Pediatrics|October 1, 1983
Chronic active Epstein-Barr virus infections in two immunodeficient patientsD Hellmann, M J Cowan, A J Ammann, et al.
Pediatrics|March 1, 1984
Maternal transmission of acquired immune deficiency syndromeM J Cowan, D Hellmann, D Chudwin, et al.
Journal of Oral Rehabilitation|April 10, 2014
Localised task-dependent motor-unit recruitment in the masseterH J Schindler, D Hellmann, N N Giannakopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2014
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testingH A Yu, M E Arcila, M D Hellmann, et al.
JTO Clinical and Research Reports|September 30, 2021
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLCNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
JAMA Dermatology|December 13, 2018
Clinical Characterization of Immunotherapy-Related Pruritus Among Patients Seen in 2 Oncodermatology ClinicsGregory S Phillips, Azael Freites-Martinez, Jennifer Wu, et al.
Clinical Lung Cancer|May 25, 2015
Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung CancersMatthew D Hellmann, Isrid Sturm, Zuzana Jirakova Trnkova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinibMatthew D Hellmann, Boris Reva, Helena Yu, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1991
Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cellsM Schmitt, N Chucholowski, E Busch, et al.
IEEE Transactions on Medical Imaging|July 25, 2018
Multiple Resolution Residually Connected Feature Streams for Automatic Lung Tumor Segmentation From CT ImagesJue Jiang, Yu-Chi Hu, Chia-Ju Liu, et al.
Pageof 24